Director, Access Strategy & Marketing
Revolution Medicines
Summary
The Director of Access Strategy & Marketing will lead the development and execution of access strategies, non-clinical positioning, and marketing materials for the RevMed portfolio with a focus on pancreatic adenocarcinoma (PDAC) or non-small cell lung cancer (NSCLC). This role will focus on developing the short to medium term non-clinical value proposition across payers, HCPs, organized customers (GPOs, IDNs, etc.) and channel partners. This role will be instrumental in supporting a successful launch through strategy and tactical planning, tailoring messages to various customer types, and working cross-functionally with Brand Marketing, National Account, Medical/HEOR, Regulatory and Compliance partners.
Job description
The Opportunity
The Director of Access Strategy & Marketing will lead the development and execution of access strategies, non-clinical positioning, and marketing materials for the RevMed portfolio with a focus on pancreatic adenocarcinoma (PDAC) or non-small cell lung cancer (NSCLC). This role will focus on developing the short to medium term non-clinical value proposition across payers, HCPs, organized customers (GPOs, IDNs, etc.) and channel partners. This role will be instrumental in supporting a successful launch through strategy and tactical planning, tailoring messages to various customer types, and working cross-functionally with Brand Marketing, National Account, Medical/HEOR, Regulatory and Compliance partners.
Responsibilities
- Lead the development and execution of access marketing strategies to align with cross-functional priorities and portfolio objectives.
- Set the direction and develop value proposition messaging and materials tailored to payers, PBMs, IDNs, GPOs, channel partners, and other decisionmakers.
- Influence clinical, economic, and real-world evidence plans and translate into compelling messages that communicate the portfolio's value and address stakeholder evidence needs.
- Develop and execute a customer insights plan and partner with national accounts and field leadership to translate customer insights into strategy and materials.
- Direct compliant marketing tactics for GPOs and organized providers across relevant channels.
- Lead pull-through and training for materials and market access initiatives.
- Lead Market Access launch readiness, align access teams around shared priorities, and represent Market Access in cross-functional forums.
- Guide educational initiatives that strengthen internal and external understanding of RevMed's market access programs.
- Oversee day-to-day agency projects, timelines, deliverables, and assigned budgets.
- Partner with Brand Marketing, Regulatory, and Compliance to ensure materials advance brand goals and meet compliance requirements.
Required Skills, Experience and Education
- Bachelor's degree required with 10+ years of experience in Marketing, Product Planning, and/or Managed Care.
- Experience in new product launches, including strategy development and tactical execution.
- Strong understanding of the access landscape across all market access stakeholders.
- Prior experience with developing co-positioning strategies across multiple assets and identifying portfolio tradeoffs.
- Excellent organizational skills and ability to prioritize and effectively deliver results within established timelines.
- Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication.
- Ability to travel up to 25%.
Preferred Skills
- 12+ years of experience in Marketing and/or Managed Care.
- Oral oncolytic product experience strongly.
- Understanding of distribution models, patient support programs, US public policy, and reimbursement dynamics.
- Prior experience working with Compliance and Regulatory teams.
- Prior experience in customer-facing roles.
Requirements
- Bachelor's degree required
- 10+ years of experience in Marketing, Product Planning, and/or Managed Care
- Experience in new product launches, including strategy development and tactical execution
- Strong understanding of the access landscape across all market access stakeholders
- Prior experience with developing co-positioning strategies across multiple assets and identifying portfolio tradeoffs
- Excellent organizational skills and ability to prioritize and effectively deliver results within established timelines
- Strong interpersonal skills including verbal and written communication
- Ability to travel up to 25%
Benefits
- Competitive cash compensation
- Robust equity awards
- Strong benefits
- Learning and development opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.